GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells

RJ Fernandez, ZJG Gardner, KJ Slovik, DC Liberti… - Elife, 2022 - elifesciences.org
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …
被引用次数：11 相关文章

GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells.

RJ Fernandez, ZJG Gardner, KJ Slovik, DC Liberti… - eLife, 2022 - go.gale.com
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …

GSK3 Inhibition Rescues Growth and Telomere Dysfunction in Dyskeratosis Congenita IPSC-Derived Type II Alveolar Epithelial Cells

RJ Fernandez - 2022 - search.proquest.com
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …

GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells.

RJ Fernandez, ZJG Gardner, KJ Slovik, DC Liberti… - Elife, 2022 - europepmc.org
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …
[HTML] nih.gov

[HTML][HTML] GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells

RJ Fernandez, ZJG Gardner, KJ Slovik, DC Liberti… - eLife, 2022 - ncbi.nlm.nih.gov
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …

GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells

RJ Fernandez, ZJG Gardner, KJ Slovik, DC Liberti… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …

GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells.

RJ Fernandez, ZJG Gardner, KJ Slovik, DC Liberti… - eLife, 2022 - search.ebscohost.com
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …
[PDF] upenn.edu

[PDF][PDF] GSK3 INHIBITION RESCUES GROWTH AND TELOMERE DYSFUNCTION IN DYSKERATOSIS CONGENITA IPSC-DERIVED TYPE II ALVEOLAR EPITHELIAL …

RJ Fernandez - 2022 - repository.upenn.edu
F. Brad Johnson Dyskeratosis congenita (DC) is a rare genetic disorder characterized by
deficiencies in telomere maintenance leading to very short telomeres and the premature …

GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells

RJ Fernandez, ZJG Gardner, KJ Slovik, DC Liberti… - 2022 - agris.fao.org
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …

Gsk3 Inhibition Rescues Growth And Telomere Dysfunction In Dyskeratosis Congenita Ipsc-Derived Type Ii Alveolar Epithelial Cells

RJ Fernandez - 2022 - repository.upenn.edu
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in
telomere maintenance leading to very short telomeres and the premature onset of certain …